MA30326B1 - Agent pour la prevention/le traitement du syndrome du colon irritable - Google Patents
Agent pour la prevention/le traitement du syndrome du colon irritableInfo
- Publication number
- MA30326B1 MA30326B1 MA31272A MA31272A MA30326B1 MA 30326 B1 MA30326 B1 MA 30326B1 MA 31272 A MA31272 A MA 31272A MA 31272 A MA31272 A MA 31272A MA 30326 B1 MA30326 B1 MA 30326B1
- Authority
- MA
- Morocco
- Prior art keywords
- optionally substituted
- treatment
- substituted hydrocarbon
- prevention
- agent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Abstract
La présente invention concerne un agent prophylactique ou thérapeutique pour le traitement du syndrome de l'intestin irritable, qui comprend un composé représenté par la formule (I) : dans laquelle, R1 représente un groupe hydrocarboné éventuellement substitué, etc., R2 représente un atome d'hydrogène ou un groupe hydrocarboné éventuellement substitué, R3 représente un atome d'hydrogène, un groupe hydrocarboné éventuellement substitué, etc., X représente CHR4, NR4, CO, O ou S (où R4 représente un atome d'hydrogène, un groupe hydrocarboné éventuellement substitué, etc.), Y représente C, CH ou N, ---- représente une simple liaison ou une double liaison, le cycle A représente un hétérocycle à 5 ou 7 chaînons éventuellement substitué contenant de l'oxygène, le cycle B représente un cycle benzène éventuellement substitué et m représente un nombre entier de 1 à 4, ou l'un de ses sels.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006076532 | 2006-03-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA30326B1 true MA30326B1 (fr) | 2009-04-01 |
Family
ID=38522471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA31272A MA30326B1 (fr) | 2006-03-20 | 2008-10-07 | Agent pour la prevention/le traitement du syndrome du colon irritable |
Country Status (19)
Country | Link |
---|---|
US (2) | US20090048325A1 (fr) |
EP (1) | EP1997488A4 (fr) |
JP (1) | JP5219799B2 (fr) |
KR (1) | KR20080114743A (fr) |
CN (1) | CN101404994A (fr) |
AR (1) | AR059935A1 (fr) |
AU (1) | AU2007228087A1 (fr) |
BR (1) | BRPI0708805A2 (fr) |
CA (1) | CA2644181A1 (fr) |
CR (1) | CR10267A (fr) |
IL (1) | IL193686A0 (fr) |
MA (1) | MA30326B1 (fr) |
MX (1) | MX2008011969A (fr) |
NO (1) | NO20084214L (fr) |
PE (1) | PE20080122A1 (fr) |
RU (1) | RU2008141305A (fr) |
TW (1) | TW200803837A (fr) |
WO (1) | WO2007108442A1 (fr) |
ZA (1) | ZA200807752B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023059546A1 (fr) * | 2021-10-04 | 2023-04-13 | Psilosterics, Llc | Agonistes du récepteur de la sérotonine et leurs méthodes de fabrication et d'utilisation |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9326192D0 (en) * | 1993-12-22 | 1994-02-23 | Glaxo Group Ltd | Chemical compounds |
HU224220B1 (hu) * | 1996-03-08 | 2005-06-28 | Takeda Pharmaceutical Company Limited | Triciklusos vegyületek, eljárás előállításukra és alkalmazásuk |
JP2884153B2 (ja) * | 1996-03-08 | 1999-04-19 | 武田薬品工業株式会社 | 三環性化合物、その製造法および剤 |
US6034239A (en) * | 1996-03-08 | 2000-03-07 | Takeda Chemical Industries, Ltd. | Tricyclic compounds, their production and use |
ATE247967T1 (de) * | 1998-06-09 | 2003-09-15 | Takeda Chemical Industries Ltd | Pharmazeutische kombination mit einem trizyclischen komponent und mindestens einem aus zolpidem, zopiclone und brotizolam, zur behandlung von schlafstörungen |
FR2795323B1 (fr) * | 1999-06-23 | 2001-11-16 | Adir | Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal |
JP2002226367A (ja) | 2001-02-02 | 2002-08-14 | Fuji Chem Ind Co Ltd | 薬物障害の予防または治療剤 |
US20050203130A1 (en) * | 2003-12-02 | 2005-09-15 | Erik Buntinx | Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
US20070088079A1 (en) * | 2005-09-20 | 2007-04-19 | Takeda Pharmaceutical Company Limited | Prophylactic or therapeutic agent for sleep disorder |
AR056076A1 (es) * | 2005-09-20 | 2007-09-19 | Takeda Pharmaceutical | Agente profilactico o terapeutico para el desorden de sueno |
US8138174B2 (en) * | 2007-01-10 | 2012-03-20 | Solvay Pharmaceuticals B.V. | Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition |
-
2007
- 2007-03-19 CA CA002644181A patent/CA2644181A1/fr not_active Abandoned
- 2007-03-19 CN CNA2007800101941A patent/CN101404994A/zh active Pending
- 2007-03-19 AU AU2007228087A patent/AU2007228087A1/en not_active Abandoned
- 2007-03-19 ZA ZA200807752A patent/ZA200807752B/xx unknown
- 2007-03-19 AR ARP070101099A patent/AR059935A1/es unknown
- 2007-03-19 RU RU2008141305/15A patent/RU2008141305A/ru not_active Application Discontinuation
- 2007-03-19 JP JP2008506294A patent/JP5219799B2/ja not_active Expired - Fee Related
- 2007-03-19 TW TW096109297A patent/TW200803837A/zh unknown
- 2007-03-19 KR KR1020087022827A patent/KR20080114743A/ko not_active Application Discontinuation
- 2007-03-19 MX MX2008011969A patent/MX2008011969A/es not_active Application Discontinuation
- 2007-03-19 BR BRPI0708805-1A patent/BRPI0708805A2/pt not_active Application Discontinuation
- 2007-03-19 EP EP07738971A patent/EP1997488A4/fr not_active Withdrawn
- 2007-03-19 PE PE2007000293A patent/PE20080122A1/es not_active Application Discontinuation
- 2007-03-19 WO PCT/JP2007/055526 patent/WO2007108442A1/fr active Application Filing
- 2007-03-19 US US12/225,269 patent/US20090048325A1/en not_active Abandoned
-
2008
- 2008-08-25 IL IL193686A patent/IL193686A0/en unknown
- 2008-08-29 CR CR10267A patent/CR10267A/es not_active Application Discontinuation
- 2008-10-07 MA MA31272A patent/MA30326B1/fr unknown
- 2008-10-08 NO NO20084214A patent/NO20084214L/no not_active Application Discontinuation
-
2010
- 2010-06-29 US US12/826,473 patent/US8183285B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ZA200807752B (en) | 2009-12-30 |
JP5219799B2 (ja) | 2013-06-26 |
NO20084214L (no) | 2008-10-08 |
CA2644181A1 (fr) | 2007-09-27 |
AU2007228087A1 (en) | 2007-09-27 |
CR10267A (es) | 2008-11-18 |
KR20080114743A (ko) | 2008-12-31 |
JPWO2007108442A1 (ja) | 2009-08-06 |
BRPI0708805A2 (pt) | 2011-06-14 |
EP1997488A4 (fr) | 2010-04-21 |
US20100267821A1 (en) | 2010-10-21 |
US8183285B2 (en) | 2012-05-22 |
MX2008011969A (es) | 2008-10-03 |
US20090048325A1 (en) | 2009-02-19 |
AR059935A1 (es) | 2008-05-07 |
WO2007108442A1 (fr) | 2007-09-27 |
EP1997488A1 (fr) | 2008-12-03 |
RU2008141305A (ru) | 2010-04-27 |
TW200803837A (en) | 2008-01-16 |
CN101404994A (zh) | 2009-04-08 |
PE20080122A1 (es) | 2008-04-24 |
IL193686A0 (en) | 2009-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA30890B1 (fr) | Compose indole | |
MA29250B1 (fr) | Cyclohexylamides servant d'antagonistes des recepteurs de dopamine d3, d2 et de 5ht1a | |
HUP0203165A2 (hu) | Nitrogént tartalmazó, öttagú heterociklusos vegyületek | |
MA32171B1 (fr) | Compose heterocyclique | |
TNSN08337A1 (fr) | Piperidinoylpyrrolidines agonistes du recepteur de melanocortine de type 4 | |
TN2009000204A1 (fr) | Spirocetones servant d'inhibiteurs d'acetyl-coa-carboxylase | |
TNSN06358A1 (fr) | Methyl-aryl-ou-heteroaryl-amides substitues | |
EA200600364A1 (ru) | Производные (тио)карбамоилциклогексана в качестве антагонистов d/dрецептора | |
MA33581B1 (fr) | Composition pharmaceutique contenant un dérivé de quinoléine | |
MA30911B1 (fr) | Nouveaux derives de sulfonamide en tant qu'antagonistes de bradykinine | |
MY153045A (en) | Oxopyrazine derivative and herbicide | |
MA30355B1 (fr) | Derives d'azabicyclo [3. 1. 0] hexyle utilises comme modulateurs des recepteurs de la dopamine d3 | |
MA31710B1 (fr) | (carboxylalkylenephenyl)phényloxamides, procédés pour la production de ceux-ci et utilisation de ceux-ci en tant que medicament | |
MA33209B1 (fr) | Inhibiteurs de la replication du virus de l'hepatite c | |
EA200600527A1 (ru) | Активирующее ppar соединение и содержащая его фармацевтическая композиция | |
MA32965B1 (fr) | Derives de sulfonamides | |
TW200745034A (en) | New compounds | |
MA32283B1 (fr) | Composes cycliques condenses et utilisation de ceux-ci | |
MA34361B1 (fr) | Dérivés de tétrahydro-pyrido-pyrimidine | |
TR200103218T2 (tr) | Yeni trisiklik bileçikler ve bunlarìn ilalarda kullanìmì. | |
TW200745058A (en) | MMP-13 selective inhibitors | |
MA31323B1 (fr) | Agents therapeutiques | |
MA33569B1 (fr) | Ligands sigma pour la prevention ou le traitement de la douleur induite par la chimiotherapie | |
MA33836B1 (fr) | Compositions pharmaceutiques contenant des ligands des récepteurs sigma | |
MA30916B1 (fr) | Nouveaux derives de benzamide en tant qu'antagonistes de bradykinine |